LIMN   $0.1866  6.63% Market Closed After Close 0.1993 6.81%

Liminatus Pharma, Inc.

EMA (20): 2026-02-11 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2026-02-11 the price crossed down the moving average line and demonstrates a downside trend.

EMA (100): 2026-02-09 the price crossed down the moving average line and formed a short-term downside trend.

MACD: Oscillator MACD is in the negative territory it crossed the signal line from the bottom and grows. These factors mean that the market confirms the end of the downward trend. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

Trend Type down and flat
Power slow
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -61.45%
EMA (20) date of signal Feb. 11, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -61.45%
EMA (50) date of signal Feb. 11, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -84.12%
EMA (100) date of signal Feb. 9, 2026, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -5.07%
RSI (14) date of signal March 2, 2026, 3 a.m.
MACD Signals bullish reversal
MACD Yield 0.0
MACD date of signal March 3, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -5.07%
Stochastic date of signal March 2, 2026, 3 a.m.
Updated March 4, 2026, 8:37 p.m.